MedTrace Logo

Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury

NCT01209169 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 890

Last updated 2013-02-22

No results posted yet for this study

Summary

The purpose of this study is to collect blood and urine samples that may help identify and validate biomarkers for the early detection and risk assessment of acute kidney injury (AKI).

Conditions

Sponsors & Collaborators

  • Astute Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • John Kellum, MD · Professor, Critical Care Medicine, University of Pittsburgh

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-04-30
Completion
2013-02-28

Countries

  • United States
  • Austria
  • Canada
  • France
  • Germany
  • Spain
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01209169 on ClinicalTrials.gov